George L. Sing, a Director at Regeneron Pharmaceuticals, Inc. (REGN), executed a sale of 7,073 shares on November 4, 2026. The transaction, valued at approximately $6.83 million, occurred at an average price of $965.38 per share.
This activity follows other notable insider sales at Regeneron in early November. Joseph J. LaRosa and George L. Sing also reported multiple sell transactions on November 2, 2026, totaling hundreds of thousands and millions of dollars respectively.
Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or adherence to pre-arranged trading plans. Such transactions do not necessarily indicate a negative sentiment towards the company's future performance.